Use of vasoactive medications in pregnancy and the risk of stillbirth among birth defect cases.
Stephen M KerrDominique HeinkeMahsa M YazdyAllen A MitchellAnne Marie DarlingAngela LinEirini NestoridiMartha M Werlernull nullPublished in: Birth defects research (2022)
This exploratory analysis of vasoactive medication use suggests that use of NSAIDs, decongestants, and SABA/LABA is not associated with increased risk of stillbirth among pregnancies affected with birth defects. Our finding of increased risks associated with antihypertensive medication use raises questions of confounding by indication, which we were not able to fully address.